A drug commonly used to shrink enlarged prostate glands also increases the accuracy of the test used to detect aggressive forms of prostate cancer, Washington University researchers have found. Dr.
Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly. Diagnosis involves the TNM system, Gleason score, PSA tests, and imaging to ...